Amgen buys deCODE genetics for $415mm in cash
Amgen Inc. has acquired closely held human genetics firm deCODE genetics EHF for $415mm in cash.
- In Vitro Diagnostics
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Drug Discovery Tools
- Acquisition of Private Biotech
- Full Acquisition
- Payment Includes Cash for Equity
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.